{"id":"CHEMBL1016","canonicalSmiles":"CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1","inchiKey":"HTQMVQVXFRQIKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANDESARTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CV-11974","Candesartan","Candesartan cilexetil related compound g"],"crossReferences":{"PubChem":["144206031","170466386","50112728"],"Wikipedia":["Candesartan"],"drugbank":["DB13919"],"chEBI":["3347"]},"count":22,"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0002610","EFO_0000275","EFO_0000373","EFO_0000266","EFO_0000538","HP_0100543","EFO_0003144","EFO_0000712","EFO_0003100","EFO_0005295","EFO_1002032","EFO_0008573","EFO_0004701","EFO_0003047","EFO_0000400","HP_0001653","EFO_0000280","EFO_0005296","EFO_0003821","EFO_0000319","EFO_1001496","EFO_0000537","EFO_0003896","MONDO_0002491","MONDO_0100096","EFO_0001359","EFO_0001360"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 22 investigational indications."}
{"id":"CHEMBL1017","canonicalSmiles":"CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1","inchiKey":"RMMXLENWKUUMAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TELMISARTAN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Micardis","Telmisartan","Tolura"],"synonyms":["BIBR 277 SE","BIBR-277","BIBR-277 SE","BIBR-277-SE","BIBR-277SE","C09CA07","Telmisartan"],"crossReferences":{"DailyMed":["telmisartan"],"PubChem":["137275807","144205005","170464873","26719833","26749005","49648460"],"Wikipedia":["Telmisartan"],"drugbank":["DB00966"],"chEBI":["9434"]},"count":10,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0003777","EFO_0008620","EFO_0003095","EFO_0000275","EFO_0000401","EFO_0000180","EFO_0000249","EFO_0004997","EFO_0000373","EFO_0000319","EFO_1001461","Orphanet_309005","EFO_0000537","EFO_0000195","MONDO_0100096","EFO_0000764","EFO_0003884","EFO_0000712","EFO_1002032","EFO_0001360","EFO_0003918","EFO_0005411","EFO_0000692","EFO_0004285"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for cardiovascular disease and hypertension and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL107201","canonicalSmiles":"N=C(N)SCCc1cccc(CCSC(=N)N)c1","inchiKey":"YEUSLPIIQGZHQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL107201","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111671"],"drugbank":["DB03910"]},"childChemblIds":["CHEMBL1255742","CHEMBL1527769"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1084173","canonicalSmiles":"O=C(O)/C(=C/c1ccccc1)c1ccccc1.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O","inchiKey":"KAMFDHLRBHTIMJ-AZDLLSQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VILANTEROL .ALPHA.-PHENYL CINNAMATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-642444H","GW642444H","Gw642444h","Vilanterol .alpha.-phenyl cinnamate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1106","canonicalSmiles":"NC1=NCC2c3ccccc3Cc3ccccc3N12","inchiKey":"WHWZLSFABNNENI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPINASTINE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Elestat","Epinastine","WAL-801"],"crossReferences":{"DailyMed":["epinastine%20hydrochloride"],"PubChem":["29217549","50111706","90340676"],"Wikipedia":["Epinastine"],"drugbank":["DB00751"],"chEBI":["51032"]},"childChemblIds":["CHEMBL1200491"],"count":5,"approvedIndications":["EFO_0005751","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0007141","EFO_0005751","EFO_1001417","EFO_0003956","EFO_0003785"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for eye allergy and allergy and has 3 investigational indications."}
{"id":"CHEMBL111","canonicalSmiles":"Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1","inchiKey":"JZCPYUJPEARBJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMONABANT","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," Never approved in the United States"],"classes":["Psychiatric toxicity"],"year":2008},"tradeNames":["Acomplia"],"synonyms":["Rimonabant","SR-14171","SR-141716","SR-141716A","SR141716"],"crossReferences":{"PubChem":["144205753","170465599","26757994"],"Wikipedia":["Rimonabant"],"drugbank":["DB06155"],"chEBI":["34967"]},"childChemblIds":["CHEMBL558598"],"count":15,"approvedIndications":["EFO_0001073"],"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","HP_0001397","EFO_0006501","EFO_0004329","EFO_0003768","EFO_0000319","HP_0001824","EFO_0001073","EFO_0003843","Orphanet_309005","EFO_0007191","EFO_0003914","EFO_0000195","Orphanet_739","EFO_1001121","MONDO_0021661","EFO_0009086","EFO_0001360","HP_0012594"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for obesity and has 14 investigational indications. It was withdrawn in European Union and  Never approved in the United States initially in 2008 due to Psychiatric toxicity."}
{"id":"CHEMBL1111","canonicalSmiles":"COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O","inchiKey":"OUJTZYPIHDYQMC-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMBRISENTAN","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Letairis","Volibris"],"synonyms":["Ambrisentan","GSK-1325760","GSK-1325760A","GSK1325760","GSK1325760A","LU-208075"],"crossReferences":{"DailyMed":["ambrisentan"],"PubChem":["144205520","170465143"],"Wikipedia":["Ambrisentan"],"drugbank":["DB06403"]},"count":9,"approvedIndications":["Orphanet_422","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["MONDO_0005149","EFO_0001361","Orphanet_232","Orphanet_422","EFO_0000768","EFO_0009197","EFO_0000270","EFO_1000782","MONDO_0004933","EFO_0004264","EFO_0000537"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for idiopathic and/or familial pulmonary arterial hypertension and hypertension and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL11672","canonicalSmiles":"CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1","inchiKey":"SGOOQMRIPALTEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROQUINIMEX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FCF 89","LS 2616","Linomide","Roquinimex"],"crossReferences":{"PubChem":["11114093","144204502","170466254"],"drugbank":["DB11366"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1184","canonicalSmiles":"CC(=O)OCC[N+](C)(C)C.[Cl-]","inchiKey":"JUGOREOARAHOCO-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLCHOLINE CHLORIDE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL667","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Miochol","Miochol-e","Miphtel"],"synonyms":["Acetylcholine","Acetylcholine Chloride","Acetylcholine chloride","Acetylcholine chloride for injection","Miochol","Miochol-E"],"crossReferences":{"PubChem":["11532873","170464783","26747837"],"chEBI":["2417"]},"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_1001461"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973."}
{"id":"CHEMBL1187724","canonicalSmiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2","inchiKey":"PIPAJLPNWZMYQA-KNCRFDSUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLATROPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methylatropine"],"crossReferences":{"drugbank":["DB13833"]},"childChemblIds":["CHEMBL2146143","CHEMBL516476"],"count":1,"approvedIndications":["EFO_0010282"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1200416","canonicalSmiles":"CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1.[Na+]","inchiKey":"PQMSFAORUFMASU-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACETAMIDE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL455","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bleph-10","Bleph-30","Cetamide","Isopto Cetamide","Klaron","Ocusulf-10","Ocusulf-30","Sodium Sulamyd","Sodium Sulfacetamide","Sulf-10","Sulf-15","Sulfacel-15","Sulfacetamide Sodium","Sulfair 10","Sulfair Forte","Sulfair-15","Sulten-10"],"synonyms":[],"crossReferences":{"chEBI":["9327"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200799","canonicalSmiles":"CC(C)OC(=O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1","inchiKey":"MKPLKVHSHYCHOC-AHTXBMBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAVOPROST","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Izba","Travatan","Travatan z","Travoprost"],"synonyms":["AL-6221","Travoprost"],"crossReferences":{"DailyMed":["travoprost"],"Wikipedia":["Travoprost"],"drugbank":["DB00287"],"chEBI":["746859"]},"count":3,"approvedIndications":["EFO_0004190","EFO_1001069","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_1000906","MONDO_0001744","EFO_0004208","EFO_0000516","EFO_0003822","EFO_0004235"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved indications."}
{"id":"CHEMBL1200977","canonicalSmiles":"CC(O)C(=O)O.Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1","inchiKey":"VWUPWEAFIOQCGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILRINONE LACTATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL189","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Milrinone lactate","Primacor"],"synonyms":["Milrinone lactate"],"crossReferences":{"DailyMed":["milrinone%20lactate"],"chEBI":["34850"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1987."}
{"id":"CHEMBL1201013","canonicalSmiles":"O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]","inchiKey":"ZJEFYLVGGFISGT-VRZXRVJBSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"OLSALAZINE SODIUM","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL425","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dipentum"],"synonyms":["Ads","Azodisal sodium","CJ 91B","CJ-91B","Olsalazine sodium","Sodium azodisalicylate"],"crossReferences":{"DailyMed":["olsalazine%20sodium"]},"count":1,"approvedIndications":["EFO_0000729"],"linkedTargets":{"rows":["ENSG00000132170","ENSG00000012779","ENSG00000073756","ENSG00000095303"],"count":4},"linkedDiseases":{"rows":["EFO_0000729"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990 and is indicated for ulcerative colitis."}
{"id":"CHEMBL1201159","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl","inchiKey":"LHCBOXPPRUIAQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENTANYL HYDROCHLORIDE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL596","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ionsys"],"synonyms":["Fentanyl hydrochloride"],"count":1,"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2006 and has 1 investigational indication."}
{"id":"CHEMBL1201198","canonicalSmiles":"Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12","inchiKey":"HIANJWSAHKJQTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEMIROLAST","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pemirolast"],"crossReferences":{"PubChem":["50112688"],"Wikipedia":["Pemirolast"],"drugbank":["DB00885"]},"childChemblIds":["CHEMBL1201050"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 4 investigational indications."}
{"id":"CHEMBL1201218","canonicalSmiles":"Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](OC=O)c3ccccc3)[C@H]2SC1","inchiKey":"RRJHESVQVSRQEX-SUYBPPKGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAMANDOLE NAFATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mandol"],"synonyms":["106223","Cefamandole nafate"],"crossReferences":{"PubChem":["124894241"],"drugbank":["DB14725"],"chEBI":["53654"]},"childChemblIds":["CHEMBL1618"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978."}
{"id":"CHEMBL1201300","canonicalSmiles":"CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I","inchiKey":"UXIGWFXRQKWHHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IOTHALAMIC ACID","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Iotalamic acid","Iothalamic acid","MI-216"],"crossReferences":{"DailyMed":["iothalamate%20meglumine","iothalamate%20sodium%20i-125"],"drugbank":["DB09133"]},"childChemblIds":["CHEMBL1201125","CHEMBL2104998","CHEMBL2106318","CHEMBL1097620","CHEMBL1201123"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201473","drugType":"Small molecule","blackBoxWarning":false,"name":"COLESEVELAM HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cholestagel","Welchol"],"synonyms":["Colesevelam","Colesevelam hydrochloride","GT-31-104HB","GT31-104HB","IW-3718"],"crossReferences":{"DailyMed":["colesevelam%20hydrochloride"],"DrugCentral":["4405"]},"count":8,"approvedIndications":["EFO_0001360","EFO_0004911"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for type ii diabetes mellitus and familial hypercholesterolemia and has 6 investigational indications."}
{"id":"CHEMBL1201642","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP PROMPT BEEF","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Semilente insulin"],"synonyms":["Insulin zinc susp prompt beef"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201729","canonicalSmiles":"CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1.Cl","inchiKey":"DWKVCQXJYURSIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DRONEDARONE HYDROCHLORIDE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL184412","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Multaq"],"synonyms":["Dronedarone HCl","Dronedarone hydrochloride","SR33598B"],"crossReferences":{"DailyMed":["dronedarone%20hydrochloride"]},"count":1,"approvedIndications":["EFO_0000275"],"linkedTargets":{"rows":["ENSG00000136546","ENSG00000157388","ENSG00000151067","ENSG00000123700","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000081248","ENSG00000102001","ENSG00000144285","ENSG00000169432","ENSG00000138622","ENSG00000136531","ENSG00000153253"],"count":16},"linkedDiseases":{"rows":["EFO_0000275"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2009 and is indicated for atrial fibrillation. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229211","canonicalSmiles":"C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N21","inchiKey":"RHWKPHLQXYSBKR-BMIGLBTASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLUTEGRAVIR","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tivicay"],"synonyms":["Dolutegravir","GSK 1349572","GSK-1349572","GSK1349572","S-349572"],"crossReferences":{"DailyMed":["dolutegravir%20sodium"],"Wikipedia":["Dolutegravir"],"drugbank":["DB08930"],"chEBI":["76010"]},"childChemblIds":["CHEMBL1213165"],"count":6,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for viral disease and has 5 investigational indications."}
{"id":"CHEMBL1230988","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@@H]4CC(=O)CC[C@]34C)[C@@H]1CCC2=O","inchiKey":"RAJWOBJTTGJROA-QJISAEMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230988","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["85148342"],"drugbank":["DB07375"],"chEBI":["16985"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230997","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O[C@H]2[C@@H](O)[C@@H](NC(C)=O)[C@H](O[C@@H]3[C@@H](CO)[C@@H]4OC(N(C)C)=N[C@@H]4[C@H]3O)O[C@@H]2CO)O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"MDWNFWDBQGOKNZ-XYUDZHFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLOSAMIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allosamidin"],"crossReferences":{"drugbank":["DB04628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL12318","canonicalSmiles":"O=P(O)(O)C(Cl)(Cl)P(=O)(O)O","inchiKey":"ACSIXWWBWUQEHA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLODRONIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clodronic acid"],"crossReferences":{"PubChem":["90340757"],"Wikipedia":["Clodronic_acid"],"drugbank":["DB00720"],"chEBI":["110423"]},"childChemblIds":["CHEMBL1520188"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1234","canonicalSmiles":"CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O","inchiKey":"IDDIJAWJANBQLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFEROXAMINE MESYLATE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL556","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deferoxamine mesylate","Desferal","Desferal Mesylate","Desferrioxamine Mesylate"],"synonyms":["BA-33112","Deferoxamine mesilate","Deferoxamine mesylate","Deferoxamine methanesulfonate","Desferrioxamine mesilate"],"crossReferences":{"DailyMed":["deferoxamine%20mesylate"],"PubChem":["11112937","11533050","124882730","144204292","170464752","26747967"],"chEBI":["31460"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 2 investigational indications."}
{"id":"CHEMBL1235017","canonicalSmiles":"O=C(O)c1cc(=O)[nH]c(=O)[nH]1","inchiKey":"PXQPEWDEAKTCGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OROTIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-9791","Orotic acid"],"crossReferences":{"PubChem":["144204672","144208302","170465761","17388814","174006788"],"drugbank":["DB02262"],"chEBI":["16742"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1235084","canonicalSmiles":"O=C1CCCC/C=C/CCOC(=O)c2c(O)cc(O)c(Cl)c2C1","inchiKey":"YUZYDHRGGDTZLG-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235084","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08346"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235116","canonicalSmiles":"CCn1c2ccccc2c2cc(CNC)ccc21","inchiKey":"LBPNOEAFWYTTEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235116","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08363"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235570","canonicalSmiles":"CCCCCCCCCc1cc(O)c2ccccc2[n+]1[O-]","inchiKey":"LMBFBUICIQJLPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235570","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237046","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCCC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"HMEYVGGHISAPJR-IAHYZSEUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLITETRACYCLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Syntetrin"],"synonyms":["Rolitetracycline","SO 15,659"],"crossReferences":{"drugbank":["DB01301"],"chEBI":["63334"]},"childChemblIds":["CHEMBL2105868"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1237104","canonicalSmiles":"CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.Cl","inchiKey":"QMQBBUPJKANITL-MYXGOWFTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROPOXYPHENE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1213351","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2014},"tradeNames":["Darvon","Dolene","Doloxene","Kesso-gesic","Prophene 65","Propoxyphene hydrochloride","Propoxyphene hydrochloride 65"],"synonyms":["Dextro propoxyphene hydrochloride","Dextropropoxiphene chloride","Dextropropoxyphene","Dextropropoxyphene hydrochloride","Propoxyphene hydrochloride","Propoxyphene hydrochloride cii"],"crossReferences":{"PubChem":["144206413"],"chEBI":["8498"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for pain. It was withdrawn in United States  in 2014 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL127071","canonicalSmiles":"Cc1ncccc1OC[C@@H]1CCCN1","inchiKey":"YRVIKLBSVVNSHF-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POZANICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-87089.0","A-870890","ABT-089","Pozanicline"],"crossReferences":{"Wikipedia":["A-84,543"],"drugbank":["DB05458"]},"childChemblIds":["CHEMBL2105650"],"count":3,"linkedTargets":{"rows":["ENSG00000147434","ENSG00000160716","ENSG00000101204","ENSG00000169684"],"count":4},"linkedDiseases":{"rows":["EFO_0003888","EFO_0000249","EFO_0003768"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1290003","canonicalSmiles":"CN1[C@H]2CCC[C@@H]1C[C@H](NC(=O)c1nn(C)c3ccccc13)C2","inchiKey":"MFWNKCLOYSRHCJ-BTTYYORXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1290003","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB00889"],"chEBI":["5537"]},"childChemblIds":["CHEMBL1900758"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1293","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)C(C)(C)CCC1","inchiKey":"OENHQHLEOONYIE-JLTXGRSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETA CAROTENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betavit","Eldon","Gerard","Golden rose","Lucaratin","Lumitene","Nature's plus","Optimum","Optimun","Solatene"],"synonyms":[".beta.-carotene","Beta carotene","Beta-carotene","Betacarotene","C.I.-40800","NSC-62794"],"crossReferences":{"PubChem":["144205110","26750098","47193664","87219208"],"Wikipedia":["Beta-Carotene"],"drugbank":["DB06755"],"chEBI":["17579"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1356","canonicalSmiles":"O=C([O-])c1ccccc1.[Na+]","inchiKey":"WXMKPNITSTVMEF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM BENZOATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amzoate","Mthwsh"],"synonyms":["E-211","E211","FEMA NO. 3025","INS NO.211","INS-211","Sodium benzoate"],"crossReferences":{"DailyMed":["sodium%20benzoate"],"DrugCentral":["4373"],"PubChem":["144210445"],"Wikipedia":["Sodium_benzoate"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 2 investigational indications."}
{"id":"CHEMBL139050","canonicalSmiles":"O=C(O)C(=O)Nc1ccccc1C(=O)O","inchiKey":"QBYNNSFEMMNINN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-(Carboxyformamido)Benzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(Carboxyformamido)Benzoic Acid"],"crossReferences":{"drugbank":["DB02622"],"chEBI":["44493"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL14053","canonicalSmiles":"O=C(O)C(Cl)(Cl)Cl","inchiKey":"YNJBWRMUSHSURL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHLOROACETIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-215204","TCAA","Trichloroacetic acid","Trichloroethanoic acid"],"crossReferences":{"PubChem":["144208830","144210507","17388684","17389700","47193683"],"Wikipedia":["Trichloroacetic_acid"],"chEBI":["30956"]},"childChemblIds":["CHEMBL2028283","CHEMBL3904175"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1474129","canonicalSmiles":"Nc1cc(C(Cl)=C(Cl)Cl)c(S(N)(=O)=O)cc1S(N)(=O)=O","inchiKey":"QOVTVIYTBRHADL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORSULON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clorsulon","MK-401"],"crossReferences":{"PubChem":["11112808","124893809","144204220","144206558","170466229","26750030","56463526"],"drugbank":["DB11389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1476605","canonicalSmiles":"CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1","inchiKey":"HQVZOORKDNCGCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFOCTOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clofoctol"],"crossReferences":{"PubChem":["144204942","170466615","26748728","93576782"],"drugbank":["DB13237"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1550","canonicalSmiles":"CC1=C(C/C=C(\\C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=O)c2ccccc2C1=O","inchiKey":"MBWXNTAXLNYFJB-NKFFZRIASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PHYTONADIONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquamephyton","Kanavit","Konakion","Konakion mm","Konakion mm paed","Mephyton","Neokay","Orakay","Phylloquinone","Phytomenadione","Phytonadione","Vitamin K 1","Vitamin k1"],"synonyms":["NSC-270681","Phylloquinone e-form","Phytomenadione","Phytonadione","Vitamin k1"],"crossReferences":{"DailyMed":["phytonadione"],"PubChem":["144205208","170464798","47193669"],"Wikipedia":["Phylloquinone"],"drugbank":["DB01022"],"chEBI":["18067"]},"count":6,"approvedIndications":["MP_0001914"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1565476","canonicalSmiles":"CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O","inchiKey":"MPHPHYZQRGLTBO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APAZONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rheumox","Rheumox 600"],"synonyms":["AHR-3018","Apazone","Azapropazone","Cinnopropazone","MI-85"],"crossReferences":{"PubChem":["144204120","56463151"],"chEBI":["38010"]},"count":1,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL1567","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O","inchiKey":"LBWFXVZLPYTWQI-IPOVEDGCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUNITINIB MALATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL535","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sunitinib malate","Sutent"],"synonyms":["PHA-290940AD","SU-010398","SU-011248 L-MALATE SALT","SU010398","SU011248 L-MALATE SALT","Sunitinib malate","Sutent"],"crossReferences":{"DailyMed":["sunitinib%20malate"]},"count":53,"approvedIndications":["EFO_0000640","EFO_1001901","EFO_0000681","EFO_0000349","Orphanet_44890"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000165731","ENSG00000102755","ENSG00000037280","ENSG00000113721","ENSG00000157404","ENSG00000182578","ENSG00000122025"],"count":9},"linkedDiseases":{"rows":["EFO_0003869","EFO_1000403","EFO_0000558","EFO_0000681","EFO_1000984","EFO_0000632","EFO_1001951","EFO_0000588","MONDO_0003268","MONDO_0008903","EFO_0000182","EFO_0000501","EFO_0000641","MONDO_0015277","EFO_0000514","EFO_0000220","EFO_0000349","EFO_1001968","MONDO_0008315","MONDO_0002691","Orphanet_398934","EFO_1000576","MONDO_0044787","EFO_0001378","EFO_0000292","EFO_0002938","MONDO_0004192","EFO_1001901","EFO_0007416","EFO_1001465","MONDO_0007254","MONDO_0002087","EFO_0000350","MONDO_0020654","MONDO_0001187","Orphanet_892","MONDO_0002158","EFO_1000044","EFO_0006352","EFO_1001974","EFO_0000673","EFO_0002499","EFO_1000042","EFO_0002617","EFO_0000616","EFO_0003897","EFO_0007331","EFO_0000403","Orphanet_44890","EFO_0000222","MONDO_0007576","EFO_0003060","EFO_0000311","EFO_0000640","EFO_0003865","EFO_0006861","EFO_0000095","EFO_0000702","MONDO_0002367","MONDO_0024880","EFO_0000519","MONDO_0044926"],"count":62},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 5 approved and 48 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1576","canonicalSmiles":"C#CC1(OC(N)=O)CCCCC1","inchiKey":"GXRZIMHKGDIBEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHINAMATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Valmid"],"synonyms":["Ethinamate"],"crossReferences":{"Wikipedia":["Ethinamate"],"drugbank":["DB01031"],"chEBI":["4884"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL15967","canonicalSmiles":"c1cn[nH]c1","inchiKey":"WTKZEGDFNFYCGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1H-Pyrazole","Pyrazole"],"crossReferences":{"PubChem":["99139"],"Wikipedia":["Pyrazole"],"drugbank":["DB02757"],"chEBI":["17241"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL161","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(O)nn3C)CS[C@H]12)c1csc(N)n1","inchiKey":"VAAUVRVFOQPIGI-SPQHTLEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTRIAXONE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ceftriaxone"],"crossReferences":{"DailyMed":["ceftriaxone%20sodium"],"Wikipedia":["Ceftriaxone"],"drugbank":["DB01212"],"chEBI":["29007"]},"childChemblIds":["CHEMBL4101392","CHEMBL1200995","CHEMBL3183968"],"count":21,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for bacterial disease and has 20 investigational indications."}
{"id":"CHEMBL1614644","canonicalSmiles":"C[N+](C)([O-])CCCN1c2ccccc2CCc2ccccc21","inchiKey":"QZIQORUGXBPDSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMIPRAMINOXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imipramine oxide","Imipraminoxide"],"crossReferences":{"drugbank":["DB13782"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1615372","canonicalSmiles":"Cl.O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1","inchiKey":"NEKCRUIRPWNMLK-SCIYSFAVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LURASIDONE HYDROCHLORIDE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237021","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Latuda"],"synonyms":["Lurasidone hydrochloride","SM-13496"],"crossReferences":{"DailyMed":["lurasidone%20hydrochloride"],"chEBI":["70732"]},"count":2,"approvedIndications":["EFO_0000289","EFO_0000692"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0000289","EFO_0009963","EFO_0000692"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for bipolar disorder and schizophrenia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1625","canonicalSmiles":"COc1ccc(C(=O)c2ccccc2)c(O)c1","inchiKey":"DXGLGDHPHMLXJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYBENZONE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Uvinul m40"],"synonyms":["Oxybenzone"],"crossReferences":{"PubChem":["104171298","11112288","124882190","144203969","144209183","144213169","170465010","17389510","26747192","26752298","49718129","856513"],"Wikipedia":["Oxybenzone"],"drugbank":["DB01428"],"chEBI":["34283"]},"count":1,"approvedIndications":["EFO_0003963"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for freckles."}
{"id":"CHEMBL1627071","canonicalSmiles":"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(OP(=O)([O-])O)c2)c(OC)c1.[Na+]","inchiKey":"QVNYGLYHCNSFJE-USRGLUTNSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1627071","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1206245","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1628688","canonicalSmiles":"COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1","inchiKey":"FJHHZXWJVIEFGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZIBOTENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ZD-4054","ZD4054","Zibotentan"],"crossReferences":{"drugbank":["DB06629"]},"count":10,"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["EFO_0009708","MONDO_0008170","EFO_0001421","MONDO_0007254","EFO_0000673","EFO_0003876","MONDO_0008315","EFO_0003060","EFO_0004265","EFO_0000311","EFO_1001951"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL1630","canonicalSmiles":"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl","inchiKey":"KBTNVJNLEFHBSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMODIAQUINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL682","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Camoquin HCl"],"synonyms":["Amodiaquine HCl","TCMDC-123932"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1672627","canonicalSmiles":"O=C(Nc1cnc(-c2ccncc2F)c(-c2cccnc2)n1)C1CC1","inchiKey":"XUYURJQIMYCWBB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAS101057","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Las101057"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1690","canonicalSmiles":"CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O","inchiKey":"JCBIVZZPXRZKTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYCHLOROQUINE SULFATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1535","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ercoquin","Hydroxychloroquine sulfate","Oxichlorochine","Plaquenil","Quensyl","Quinoric"],"synonyms":["Hydroxychloroquine Sulfate","Hydroxychloroquine sulfate","Hydroxychloroquine sulphate","NSC-4375","Oxichlorochine sulfate","TCMDC-123987"],"crossReferences":{"DailyMed":["hydroxychloroquine%20sulfate"],"PubChem":["144205260","170464696","26748879"]},"count":10,"approvedIndications":["EFO_0000685"],"linkedTargets":{"rows":["ENSG00000196664","ENSG00000239732"],"count":2},"linkedDiseases":{"rows":["EFO_0002689","EFO_0000685","EFO_0001645","EFO_0004194","EFO_0003818","EFO_0001073","EFO_0005755","EFO_0005221","EFO_0003834","MONDO_0100096","EFO_0001068","EFO_0002690","EFO_0000389","EFO_0004244","EFO_0007224"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for rheumatoid arthritis and has 9 investigational indications."}
{"id":"CHEMBL1692","canonicalSmiles":"CN(C)CCCN1c2ccccc2CCc2ccccc21.Cl","inchiKey":"XZZXIYZZBJDEEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IMIPRAMINE HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL11","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imipramine hydrochloride","Janimine","Pramine","Praminil","Presamine","Sarimp","Tofranil"],"synonyms":["G-22355","Imipramine HCl","Imipramine hydrochloride","Imipramine hydrochloride rs","NSC-114900"],"crossReferences":{"DailyMed":["imipramine%20hydrochloride"],"PubChem":["144211734","26747552","26747553","26751601","50106516","50106517","50106518","56422890","855555"],"chEBI":["5882"]},"count":1,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1696","canonicalSmiles":"CNCCCN1c2ccccc2CCc2ccccc21.Cl","inchiKey":"XAEWZDYWZHIUCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESIPRAMINE HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL72","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desipramine hydrochloride","Norpramin","Pertofran","Pertofrane"],"synonyms":["18-8181","DMI","Desipramine hydrochloride","EX 4355","EX-4355","G-35020","JB-8181","NSC-114901","RMI 9,384A","RMI-9384A"],"crossReferences":{"DailyMed":["desipramine%20hydrochloride"],"PubChem":["144203680","170465424","26732610","26747493","26747494","50106122","50106123","50106124","855832","858256"],"chEBI":["4449"]},"count":3,"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0000702","HP_0003418"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1697717","canonicalSmiles":"CC1(C)[C@@H](OC(=O)CCC(=O)[O-])CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)[O-])CC[C@]3(C)CC[C@]21C.[Na+].[Na+]","inchiKey":"BQENDLAVTKRQMS-SBBGFIFASA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENOXOLONE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL499915","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biogastrone","Bioplex","Bioral","Duogastrone"],"synonyms":["Carbenoxolone Disodium","Carbenoxolone sodium"],"crossReferences":{"PubChem":["144204320","170465951"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1718","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl","inchiKey":"RGPDIGOSVORSAK-STHHAXOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALOXONE HYDROCHLORIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL80","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evzio","Evzio (autoinjector)","Nalone","Naloxone","Naloxone hydrochloride","Narcan","Narcan neonatal","Narconil","Prenoxad"],"synonyms":["EN-15304","NIH 7890","Naloxone hydrochloride"],"crossReferences":{"DailyMed":["naloxone%20hydrochloride"],"PubChem":["11532915"],"chEBI":["31892"]},"count":5,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0004699","EFO_0005611","EFO_0003843","MONDO_0004565","HP_0002019"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for pain and has 4 investigational indications."}
{"id":"CHEMBL17860","canonicalSmiles":"CC(Oc1c(Cl)cccc1Cl)C1=NCCN1","inchiKey":"KSMAGQUYOIHWFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOFEXIDINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lofexidine"],"crossReferences":{"DailyMed":["lofexidine%20hydrochloride"],"PubChem":["170466275"],"Wikipedia":["Lofexidine"],"drugbank":["DB04948"],"chEBI":["51368"]},"childChemblIds":["CHEMBL1788132"],"count":6,"approvedIndications":["EFO_0003890"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0007191","HP_0001399","EFO_0004240","EFO_0002610","EFO_0003890","EFO_0005800","EFO_0005611"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for drug dependence and has 5 investigational indications."}
{"id":"CHEMBL1863515","drugType":"Enzyme","blackBoxWarning":false,"name":"GLUCARPIDASE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Voraxaze"],"synonyms":["Glucarpidase"],"crossReferences":{"DailyMed":["glucarpidase"],"DrugCentral":["5138"]},"count":4,"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 4 investigational indications."}
{"id":"CHEMBL1887891","canonicalSmiles":"CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1.Cl","inchiKey":"ZXKXJHAOUFHNAS-FVGYRXGTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXFENFLURAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL248702","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," European Union"," Canada"," Malasia"," India"," Saudi Arabia"],"classes":["Cardiotoxicity"],"year":1997},"tradeNames":["Adifax","Redux"],"synonyms":["Dexfenfluramine hydrochloride","S 5614 HCL"],"crossReferences":{"PubChem":["144206417","170465626","85273812"],"chEBI":["59730"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom,  United States,  European Union,  Canada,  Malasia,  India and  Saudi Arabia initially in 1997 due to Cardiotoxicity."}
{"id":"CHEMBL189171","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1","inchiKey":"FSQKKOOTNAMONP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEMETACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emflex"],"synonyms":["Acemetacin"],"crossReferences":{"PubChem":["11112782","124882621","144207022","170466043","174007220","26746953","855677"],"Wikipedia":["Acemetacin"],"drugbank":["DB13783"],"chEBI":["31162"]},"count":1,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for rheumatic disease."}
{"id":"CHEMBL1907001","canonicalSmiles":"CCCCCCCCCCCC[N+](C)(C)Cc1ccccc1","inchiKey":"CYDRXTMLKJDRQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZODODECINIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzododecinium"],"crossReferences":{"drugbank":["DB13282"]},"childChemblIds":["CHEMBL2355417","CHEMBL1885899"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL191910","canonicalSmiles":"O=C1c2ccccc2C(=O)N1CCOC(=S)Nc1ccc(I)cc1","inchiKey":"CYYIBMGIJWXZEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08284"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1921904","canonicalSmiles":"C[C@@](C(=O)O[C@H]1C[N+]2(CCc3ccc(F)cc3)CCC1CC2)(c1ccccc1)N1CCCCC1","inchiKey":"FNYFFCOCVNTJCD-NNMXADRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-9164","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD9164","Azd 9164","Azd-9164","Azd9164","J3.232.015E"],"crossReferences":{"drugbank":["DB12115"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL200102","canonicalSmiles":"CC(C)NCCCn1c(Sc2cc3c(cc2I)OCO3)nc2c(N)ncnc21","inchiKey":"SUPVGFZUWFMATN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PU-H71","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PU-H 71","PU-H-71","PU-H71","PUH-71","Pu-h71"],"crossReferences":{"drugbank":["DB12638"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2002951","canonicalSmiles":"CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23.Cl","inchiKey":"HXAQGSRFKAXSNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2002951","maximumClinicalTrialPhase":0,"parentId":"CHEMBL338604","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["581714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2036513","canonicalSmiles":"Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H]([18F])C2)cc1","inchiKey":"RECBFDWSXWAXHY-CABYTMRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2036513","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2068839","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2057301","canonicalSmiles":"CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"AURFZBICLPNKBZ-FZCSVUEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEPRANOLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allopregnan-3.beta.-ol-20-one","NSC-97078","Sepranolone","U-0949","UC-1010","UC1010","Uc1010"],"crossReferences":{"drugbank":["DB12972"],"chEBI":["11909"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2062163","canonicalSmiles":"C[C@H]1[C@H](c2ccccc2)OCCN1C.O=C(O)C(O)C(O)C(=O)O","inchiKey":"VEPOHXYIFQMVHW-XOZOLZJESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENDIMETRAZINE TARTRATE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1615439","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adphen","Alphazine","Bontril","Bontril pdm","Cam-metrazine","Di-metrex","Melfiat","Melfiat-105","Metra","Phenazine","Phenazine-35","Phendimetrazine tartrate","Plegine","Sprx-105","Sprx-3","Statobex","Statobex-g","X-trozine","X-trozine l.a."],"synonyms":["Phendimetrazine tartrate"],"crossReferences":{"DailyMed":["phendimetrazine%20tartrate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL2103828","canonicalSmiles":"CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F","inchiKey":"LGSDFTPAICUONK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELINOGREL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elinogrel","PRT 060128","PRT-060128","Prt060128"],"crossReferences":{"drugbank":["DB06350"]},"childChemblIds":["CHEMBL2105641"],"count":2,"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000612"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103876","canonicalSmiles":"Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1","inchiKey":"VJGFOYBQOIPQFY-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAPRACORAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BOL-303242-X","BOL-303242X","Mapracorat","ZK 245186","ZK-245186","Zk-245186"],"crossReferences":{"drugbank":["DB12041"]},"count":6,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0003966","EFO_0001059","EFO_1000906","EFO_0000676","EFO_0007141","EFO_0000274"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2103878","canonicalSmiles":"NC(=O)c1ccc(Oc2ccc(CNCCC3CCOCC3)cc2F)nc1","inchiKey":"QWNDOCKIKKQJNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODELEPRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2196044","Ly2196044","Odelepran","Ondelopran"],"crossReferences":{"drugbank":["DB12585"]},"childChemblIds":["CHEMBL2105746"],"count":1,"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003829"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104969","canonicalSmiles":"O=C(O)c1ccc(CCCc2c(CCNS(=O)(=O)Cc3ccccc3C(F)(F)F)n(C(c3ccccc3)c3ccccc3)c3ccc(Cl)cc23)cc1","inchiKey":"NHHBNHIPCSPSHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GIRIPLADIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Giripladib","PLA-695"],"crossReferences":{"drugbank":["DB15426"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105019","canonicalSmiles":"CC(C)(C)c1ccc(CCC(O)COc2ccc(C(=O)O)cc2)cc1","inchiKey":"LNXBEIZREVRNTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIFIBROL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K 12148","K-12148","Lifibrol"],"crossReferences":{"drugbank":["DB12448"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2105161","canonicalSmiles":"CCCCOCCOC(=O)c1cccnc1","inchiKey":"IZJRISIINLJVBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOBOXIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beta-butoxyethyl nicotinate","Nicoboxil"],"crossReferences":{"PubChem":["170465989"],"drugbank":["DB12911"],"chEBI":["32322"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105671","canonicalSmiles":"O=C(O)C(O)C(O)C(=O)O.OC[C@H]1CNC[C@@H](O)[C@@H]1O","inchiKey":"ULBPPCHRAVUQMC-RWOHWRPJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFEGOSTAT TARTRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL206468","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-2101","AT2101","Afegostat tartrate","HGT-3410","Isofagomine tartrate"],"count":1,"linkedTargets":{"rows":["ENSG00000177628"],"count":1},"linkedDiseases":{"rows":["Orphanet_355"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106217","canonicalSmiles":"CCNC(C)Cc1cccc(C(F)(F)F)c1.Cl","inchiKey":"ZXKXJHAOUFHNAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENFLURAMINE HYDROCHLORIDE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL87493","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"]},"tradeNames":["Fintepla","Ponderax","Ponderax pacaps","Pondimin"],"synonyms":["AHR-3002","Fenfluramine hydrochloride","HHR-965"],"crossReferences":{"DailyMed":["fenfluramine%20hydrochloride"],"chEBI":["59729"]},"count":2,"approvedIndications":["Orphanet_33069"],"linkedTargets":{"rows":["ENSG00000179546","ENSG00000147955","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["Orphanet_33069","MONDO_0015643"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for dravet syndrome and has 1 investigational indication. It was withdrawn in United States due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2106406","canonicalSmiles":"Cc1nc2ccccc2n1CC1CCN(C(=O)/C=C(/c2ccccc2)c2ccc(/N=N/c3ccc(O)c(C(=O)O)c3)cc2)CC1","inchiKey":"RIRCDXXMYTZTPE-SDYUWQRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERSALAZINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dersalazine","UR-12746"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106480","canonicalSmiles":"CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12.Cl.Cl","inchiKey":"NOIHTGOGFDFCBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARDENAFIL DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1520","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vardenafil dihydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107433","canonicalSmiles":"c1cncc(C2=NOCC(CN3CCCCC3)N2)c1","inchiKey":"QWVRTSZDKPRPDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IROXANADINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iroxanadine"],"crossReferences":{"drugbank":["DB05444"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107636","canonicalSmiles":"Cc1nnc(SCC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)Cn4cc(Cl)c(=O)c(Cl)c4)[C@H]3SC2)s1","inchiKey":"VTLCNEGVSVJLDN-MLGOLLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAZEDONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefazedone"],"crossReferences":{"drugbank":["DB13778"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107792","canonicalSmiles":"CCN(CC)CCOC(=O)[C@H](Cc1ccc(NC(=O)c2c(Cl)cccc2Cl)cc1)NC(=O)c1c(C)cccc1Cl","inchiKey":"VZVNFRFMDNFPOM-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALATEGRAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RO-0272441","RO0272441","Valategrast"],"childChemblIds":["CHEMBL2107382"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108208","drugType":"Protein","blackBoxWarning":false,"name":"LENERCEPT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lenercept","RO 45-2081","Ro-452081"],"description":"Protein drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2108400","drugType":"Protein","blackBoxWarning":false,"name":"EMFILERMIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM-424","AM424","Emfilermin"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108727","drugType":"Gene","blackBoxWarning":false,"name":"TALIMOGENE LAHERPAREPVEC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oncovex-ae"],"synonyms":["JS-1 34.5-HGMCSF","JS1 34.5-HGMCSF 47- PA-","Talimogene laherparepvec"],"crossReferences":{"DrugCentral":["5180"]},"count":13,"approvedIndications":["EFO_0000616"],"description":"Gene drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 12 investigational indications."}
{"id":"CHEMBL2108878","drugType":"Unknown","blackBoxWarning":false,"name":"THYROID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nature"],"synonyms":["Dried thyroid","NSC-26492","Thyroid","Thyroid gland preparations"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109293","drugType":"Antibody","blackBoxWarning":false,"name":"KRN-330","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KRN-330","Krn 330","Krn-330"],"count":1,"linkedTargets":{"rows":["ENSG00000143167"],"count":1},"linkedDiseases":{"rows":["EFO_1001951"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109343","drugType":"Antibody","blackBoxWarning":false,"name":"LERONLIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leronlimab","PRO 140","PRO-140","PRO140","Pro-140"],"count":4,"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0013730","EFO_0003869","MONDO_0100096","EFO_0000764","EFO_0000180","EFO_1001249"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109411","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7444","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7444"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109466","drugType":"Antibody","blackBoxWarning":false,"name":"TNX-650","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TNX-650"],"count":1,"linkedTargets":{"rows":["ENSG00000169194"],"count":1},"linkedDiseases":{"rows":["EFO_0000183"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110587","canonicalSmiles":"O=C(NS(=O)(=O)c1ccc(Br)s1)c1ccc(Cl)cc1Cl","inchiKey":"WWONFUQGBVOKOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TASISULAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-573636","Tasisulam"],"crossReferences":{"drugbank":["DB11941"]},"childChemblIds":["CHEMBL2103823"],"count":12,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2110895","canonicalSmiles":"CCN(CC)CCOC(=O)c1cccc(-c2ccccc2)c1O","inchiKey":"HLDCSYXMVXILQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIPHENAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xenysalate"],"crossReferences":{"drugbank":["DB13815"]},"childChemblIds":["CHEMBL2106552"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110987","canonicalSmiles":"COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@H](OC)[C@@H]1OC","inchiKey":"FPGCYQVKNKEGRQ-SXLQGMKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOSERPATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metoserpate"],"crossReferences":{"drugbank":["DB11530"]},"childChemblIds":["CHEMBL2106943"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL211456","canonicalSmiles":"CN[C@@H](C)[C@H](O)c1ccccc1","inchiKey":"KWGRBVOPPLSCSI-WPRPVWTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPHEDRINE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ephedrine","NSC-170951","NSC-8971"],"crossReferences":{"DailyMed":["ephedrine%20sulfate"],"PubChem":["124892369"],"Wikipedia":["Ephedrine"],"drugbank":["DB01364"],"chEBI":["15407"]},"childChemblIds":["CHEMBL2146102","CHEMBL1523964","CHEMBL526872"],"count":9,"approvedIndications":["EFO_0000319","HP_0001742","EFO_0001073"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["HP_0001662","EFO_0004210","EFO_0000319","HP_0001742","EFO_0003843","EFO_0001073","EFO_0002950","MP_0001914","HP_0100543","EFO_0005758","EFO_0003144","EFO_0000270","EFO_0009314","EFO_0003833","EFO_0000668","EFO_0005251"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL218227","canonicalSmiles":"O=C(/C=C(\\O)c1nc[nH]n1)c1ccc(Cc2ccc(F)cc2)o1","inchiKey":"HFHDGHOGHWXXDT-ZSOIEALJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-1360","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-S-1360","GW-810781","GW810781","Gw810781","S 1360","S-1360"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2219419","canonicalSmiles":"NC(CO)(CO)CO.O=P(O)(NCCCl)NCCCl","inchiKey":"PGLRCMRTUIMSFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALIFOSFAMIDE TROMETHAMINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL889","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Palifosfamide tromethamine","ZIO-201-T"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL223147","canonicalSmiles":"CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4","inchiKey":"AOMMPEGZDRAGRC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL223147","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07266"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227072","canonicalSmiles":"COc1cc2c(cc1OC)CN(CCCCNC(=O)c1cc(C)ccc1OCC[18F])CC2","inchiKey":"QVRVXSZKCXFBTE-KPVNRNJOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227072","maximumClinicalTrialPhase":0,"parentId":"CHEMBL226539","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14900"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL227937","canonicalSmiles":"N=C(NCCC[C@H](N)CNCCN)N[N+](=O)[O-]","inchiKey":"RMSWBHUVFNFNIZ-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227937","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217478"],"drugbank":["DB02027"]},"childChemblIds":["CHEMBL481033"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228792","canonicalSmiles":"c1coc(CNc2ncnc3[nH]cnc23)c1","inchiKey":"QANMHLXAZMSUEX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KINETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kinetin"],"crossReferences":{"PubChem":["11112392","124882318","144211531","26753705","7969961"],"drugbank":["DB11336"],"chEBI":["27407"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL228814","canonicalSmiles":"Cc1ccc(C(=O)N(CCCN)[C@@H](c2nc3cc(Cl)ccc3c(=O)n2Cc2ccccc2)C(C)C)cc1","inchiKey":"QJZRFPJCWMNVAV-HHHXNRCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISPINESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ispinesib"],"crossReferences":{"drugbank":["DB06188"]},"childChemblIds":["CHEMBL2347651"],"count":10,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2296002","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)O.NCCCC[C@H](N)C(=O)O","inchiKey":"JJBCTCGUOQYZHK-ZSCHJXSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2296002","maximumClinicalTrialPhase":0,"parentId":"CHEMBL25","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2326947","canonicalSmiles":"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl.O","inchiKey":"SKZIMSDWAIZNDD-WJMOHVQJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXIFLOXACIN HYDROCHLORIDE HYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL32","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Moxifloxacin Hydrochloride Hydrate"],"crossReferences":{"PubChem":["144207165"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2338397","canonicalSmiles":"C[C@H](NC(=O)CCC(F)(F)F)C(=O)N[C@@H]1C(=O)N(CCO)c2ncccc2-c2ccccc21","inchiKey":"YCBAQKQAINQRFW-UGSOOPFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRENIGACESTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crenigacestat","LY-3039478","LY3039478"],"crossReferences":{"drugbank":["DB12050"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2362410","canonicalSmiles":"CC1(C)OC[C@@H](COC(=O)CCc2ccc(OC[C@@H](O)CNCCNC(=O)N3CCOCC3)cc2)O1.Cl","inchiKey":"DLPGJHSONYLBKP-IKGOIYPNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2362410","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1742466","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206493","144206572","170465910"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364637","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1.CC(C)OC(=O)[C@H](C)N[P@](=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)Oc1ccccc1.O=C(O)/C=C/C(=O)O","inchiKey":"SVUJNSGGPUCLQZ-FQQAACOVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TENOFOVIR ALAFENAMIDE FUMARATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2107825","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vemlidy"],"synonyms":["GS-7340 HEMIFUMARATE","GS-7340-03","Tenofovir alafenamide fumarate"],"crossReferences":{"DailyMed":["tenofovir%20alafenamide%20fumarate"]},"count":3,"approvedIndications":["EFO_0000764","EFO_0000180"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for hiv-1 infection and hiv infection and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL239800","canonicalSmiles":"CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1","inchiKey":"DWPQODZAOSWNHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOBAM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenobam","MCN-3377-98"],"crossReferences":{"PubChem":["144206177","144207065","170466272","174006275","26753296","90341711"],"Wikipedia":["Fenobam"],"drugbank":["DB12931"]},"childChemblIds":["CHEMBL2103779"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL252518","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4","inchiKey":"BJDCWCLMFKKGEE-CMDXXVQNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTENIMOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Artemether related compound a","Artenimol","Dihydroartemisinin","GNF-PF-5634"],"count":5,"approvedIndications":["EFO_0001068"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for malaria and has 4 investigational indications."}
{"id":"CHEMBL258040","canonicalSmiles":"O=C(Cc1ccc(N2CCCCC2)cc1)Nc1n[nH]c2ccc(N3CCCS3(=O)=O)cc12","inchiKey":"ZXYIRNXOAJYLCU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL258040","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07220"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL259420","canonicalSmiles":"CC(C)(C)n1nc(Cc2cccc(O)c2)c2c(N)ncnc21","inchiKey":"QMAIQPBRCNEJAT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL259420","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08461"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL271068","canonicalSmiles":"Cc1cc(NC(=O)C(=O)c2cc(Cc3ccc(C#N)cc3)n3ccccc23)sn1","inchiKey":"IZZYUABKZYIINT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSABULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rosabulin","STA-5312"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL283120","canonicalSmiles":"COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC","inchiKey":"YJGVMLPVUAXIQN-HAEOHBJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AXL-1717","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AXL-1717","Axl-1717","NSC-36407","Picropodophyllin","Picropodophyllotoxin","Podophyllotoxin picropodophyllin"],"crossReferences":{"PubChem":["29216394"],"drugbank":["DB12802"],"chEBI":["75251"]},"count":8,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001642","EFO_0000571","EFO_1001465","EFO_0002499","EFO_0002500","EFO_0002501","EFO_0000707","EFO_0003060"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL293700","canonicalSmiles":"O=[N+]([O-])c1ccc2c(c1)CN[C@@H](CO)C2","inchiKey":"RNUCRXHRBPLYTA-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL293700","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07906"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295698","canonicalSmiles":"CC(=O)N1CCN(c2ccc(OC[C@@H]3CO[C@@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1","inchiKey":"XMAYWYJOQHXEEK-ZEQKJWHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOKETOCONAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Extina","Ketosidin","Ketozole","Nizoral","Nizoral A-D","Panfungol","Xolegel"],"synonyms":["COR-003","COR003","Levoketoconazole","Nizoral","R-41400"],"crossReferences":{"PubChem":["11111347","11112822","124882653","124882654"],"drugbank":["DB05667"],"chEBI":["47518"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3039583","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O","inchiKey":"VMZMNAABQBOLAK-IXZCVAHUSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PASIREOTIDE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Signifor"],"synonyms":["Pasireotide","SOM 230","SOM-230","SOM230"],"crossReferences":{"DailyMed":["pasireotide%20diaspartate"]},"childChemblIds":["CHEMBL3039588","CHEMBL3545188"],"count":31,"linkedTargets":{"rows":["ENSG00000162009","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":4},"linkedDiseases":{"rows":["EFO_0003086","EFO_1001901","MONDO_0007254","EFO_0001071","EFO_1001110","EFO_0003099","EFO_0003860","EFO_0000182","EFO_1000067","EFO_0000673","MONDO_0015277","Orphanet_2495","EFO_0002618","EFO_1001307","EFO_1000616","EFO_0007331","EFO_1001256","EFO_0001642","EFO_0005323","MONDO_0024503","MONDO_0002108","EFO_0000232","EFO_0004243","EFO_0003843","MONDO_0008315","EFO_0000311","EFO_1001471","EFO_1000581","EFO_1001485","EFO_0008549","HP_0003074","EFO_0000702","EFO_0000432","EFO_0001378","HP_0001943","EFO_0008516"],"count":36},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and has 31 investigational indications."}
{"id":"CHEMBL307782","canonicalSmiles":"Nc1cccc(C(=O)O)c1","inchiKey":"XFDUHJPVQKIXHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-AMINOBENZOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Amino-Benzoic Acid","3-Aminobenzoic Acid","M-Aminobenzoic Acid"],"crossReferences":{"PubChem":["56422198","855737"],"Wikipedia":["3-Aminobenzoic_acid"],"drugbank":["DB02054"],"chEBI":["42682"]},"childChemblIds":["CHEMBL1762659"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3084525","canonicalSmiles":"N#Cc1ccc(N2[C@H]3CC[C@@H]2C[C@H](O)C3)c2ccccc12","inchiKey":"ATKWLNSCJYLXPF-FICVDOATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3084525","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13935"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3109802","canonicalSmiles":"COc1ncnc(Cn2cc(C(=O)NCCO)c3ncc(C)cc32)c1C","inchiKey":"VDRYGTNDKXIPSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TBA-7371","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-7371","TBA-7371","Tba-7371"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137317","canonicalSmiles":"Cc1c(C(=O)Nc2ccc(N3C[C@H](C)O[C@H](C)C3)nc2)cccc1-c1ccc(OC(F)(F)F)cc1.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"RWIVSVMMGFFZIJ-VWDRLOGHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SONIDEGIB PHOSPHATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2105737","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Odomzo"],"synonyms":["Sonidegib phosphate"],"crossReferences":{"DailyMed":["sonidegib%20phosphate"]},"count":1,"approvedIndications":["EFO_0004193"],"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0004193"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for basal cell carcinoma. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3137745","canonicalSmiles":"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl.Cl","inchiKey":"ROEBJVHPINPMKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3137745","maximumClinicalTrialPhase":0,"parentId":"CHEMBL682","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["134970489"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3184679","canonicalSmiles":"COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1","inchiKey":"VRQMAABPASPXMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-4547","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4547","Azd 4547","Azd-4547","KB-74810"],"crossReferences":{"PubChem":["174006594"]},"count":9,"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["MONDO_0001056","MONDO_0007254","EFO_0000326","MONDO_0003219","EFO_0001378","EFO_0000708","EFO_0000707","EFO_0000228","EFO_0003060","EFO_0000311","MONDO_0001187"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3189046","canonicalSmiles":"O=C([O-])COc1nn(Cc2ccccc2)c2ccccc12.[Na+]","inchiKey":"GHFGHIKJGVMEFT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3189046","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1089221","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206018","170465952"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL319111","canonicalSmiles":"O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1","inchiKey":"YEJCDKJIEMIWRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINOPIRDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DUP 996","Linopirdine"],"crossReferences":{"PubChem":["11111362","11114259","124880516","144203728","170466342","174006298","46500471","50104972","85231103","90341523"],"Wikipedia":["Linopirdine"],"drugbank":["DB13806"],"chEBI":["34823"]},"childChemblIds":["CHEMBL1612640"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3261331","canonicalSmiles":"CC(C)c1cc(Oc2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)n[nH]c1=O","inchiKey":"FDBYIYFVSAHJLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESMETIROM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGL-3196","Mgl-3196","Resmetirom","VIA-3196"],"crossReferences":{"drugbank":["DB12914"]},"count":3,"linkedTargets":{"rows":["ENSG00000151090"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","EFO_1001249","EFO_0004911"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL327097","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)O)cc1NC(=O)CO","inchiKey":"CRHJDPGLFDNPOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL327097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04565"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3287379","canonicalSmiles":"O=C1C=CN(c2c(F)cc(N3C[C@H](CNc4ccon4)OC3=O)c(F)c2F)CC1","inchiKey":"SULYVXZZUMRQAX-NSHDSACASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CONTEZOLID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Contezolid","MRX-1","MRX-I","Mrx-i"],"crossReferences":{"drugbank":["DB12796"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3301597","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC CITRATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3991241","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Auryxia"],"synonyms":["Ferric citrate","JTT-751","KRX-0502","NSC-112227"],"crossReferences":{"DrugCentral":["4538"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014 and has 1 investigational indication."}
{"id":"CHEMBL3301609","canonicalSmiles":"Cc1cc(C)c2nc(-c3cnc(NCCCC4CCN(C)CC4)nc3C)[nH]c2c1","inchiKey":"FCRFVPZAXGJLPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOREFORANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JNJ-38518168","Jnj-38518168","Toreforant"],"crossReferences":{"drugbank":["DB12522"]},"childChemblIds":["CHEMBL3301614"],"count":1,"linkedTargets":{"rows":["ENSG00000134489"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000270","EFO_0001421","EFO_0000676"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3400972","canonicalSmiles":"N[C@@H](Cc1cc(O)c(O)cc1[18F])C(=O)O","inchiKey":"PAXWQORCRCBOCU-RPDRGXCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORODOPA F 18","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3547132","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluorodopa f18"],"synonyms":["18f","Fluorodopa (18f)","Fluorodopa f 18","Fluorodopa f-18"],"crossReferences":{"DailyMed":["fluorodopa%20f-18"],"drugbank":["DB13848"],"chEBI":["49166"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 2 investigational indications."}
{"id":"CHEMBL345237","canonicalSmiles":"O=C1c2ccccc2OC=C(Cl)N1CCCCN1CC=C(c2ccccn2)CC1","inchiKey":"URMTUEWUIGOJBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICLOZOTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piclozotan","SUN-N-4057","Sun-n4057"],"crossReferences":{"drugbank":["DB12361"]},"count":2,"linkedTargets":{"rows":["ENSG00000178394"],"count":1},"linkedDiseases":{"rows":["EFO_0002508","EFO_0000712"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL348475","canonicalSmiles":"COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cc(OC)c(OC)cc3NC(=O)c3cnc4ccccc4c3)cc1)CC2","inchiKey":"LGGHDPFKSSRQNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARIQUIDAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tariquidar","XR-9576","XR9576"],"crossReferences":{"PubChem":["174006280"],"Wikipedia":["Tariquidar"],"drugbank":["DB06240"]},"childChemblIds":["CHEMBL1214643"],"count":6,"linkedTargets":{"rows":["ENSG00000085563"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","MONDO_0008903","MONDO_0008170","MONDO_0007254","EFO_1000796","EFO_0003060"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL352531","canonicalSmiles":"O=[N+]([O-])c1ccc(-c2ccccc2)cc1","inchiKey":"BAJQRLZAPXASRD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Nitro-Biphenyl","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Nitro-Biphenyl"],"crossReferences":{"drugbank":["DB12300"],"chEBI":["82504"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3542296","canonicalSmiles":"CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc([14C]#N)cc23)C1","inchiKey":"IHIWYQYVBNODSV-CTIMAWECSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3542296","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3542265","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544962","drugType":"Small molecule","blackBoxWarning":false,"name":"CT-1578","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CT-1578","Ct-1578","ONX 0805","ONX-0805","SB-1578","SB1578","Sb-1578","Sb1578"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545100","drugType":"Small molecule","blackBoxWarning":false,"name":"ASP7991","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asp7991"],"count":1,"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_1001173"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545184","canonicalSmiles":"CC(=O)N[C@H](CSSC[C@H](N)C(=O)O)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](C)C(=O)N[C@H](CCCNC(=N)N)C(N)=O","inchiKey":"ANIAZGVDEUQPRI-ZJQCGQFWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VELCALCETIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parsabiv"],"synonyms":["AMG-416","Amg416","Etelcalcetide","KAI-4169","ONO-5163","Velcalcetide"],"crossReferences":{"DailyMed":["etelcalcetide"],"drugbank":["DB12865"]},"childChemblIds":["CHEMBL3545183"],"count":3,"approvedIndications":["EFO_1001173","EFO_0005754"],"linkedTargets":{"rows":["ENSG00000036828"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","EFO_0003884","EFO_0005754"],"count":3},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for secondary hyperparathyroidism and parathyroid disease and has 1 investigational indication."}
{"id":"CHEMBL3545196","canonicalSmiles":"CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1.Cl.Cl","inchiKey":"NADLBPWBFGTESN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-0166285","maximumClinicalTrialPhase":1,"parentId":"CHEMBL49120","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pd-0166285"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545212","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-337","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 337","Amg-337"],"count":4,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003897","EFO_0008498","EFO_0000478","MONDO_0003219","EFO_0000504","EFO_0000402","EFO_0000311"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545222","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD8683","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd8683"],"count":1,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545233","canonicalSmiles":"CC[C@H](NC(=O)c1c(NS(C)(=O)=O)c(-c2ccccc2)nc2ccccc12)c1ccccc1","inchiKey":"QYTBBBAHNIWFOD-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAVINETANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZ-12472520","AZ12472520","AZ124752520","AZ4901","AZD-4901","AZD2624","AZD4901","Azd 2624","Azd 4901","Azd2624","MLE-4901","MLE4901","Pavinetant"],"crossReferences":{"drugbank":["DB11692"]},"count":2,"linkedTargets":{"rows":["ENSG00000169836"],"count":1},"linkedDiseases":{"rows":["EFO_0000692","EFO_0000660"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545320","drugType":"Small molecule","blackBoxWarning":false,"name":"ME-344","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Me 344","Me-344"],"count":2,"linkedTargets":{"rows":["ENSG00000178127","ENSG00000186010","ENSG00000137806","ENSG00000267855","ENSG00000119421","ENSG00000166136","ENSG00000198695","ENSG00000198840","ENSG00000158864","ENSG00000184983","ENSG00000168653","ENSG00000184752","ENSG00000099795","ENSG00000164258","ENSG00000065518","ENSG00000151366","ENSG00000131495","ENSG00000109390","ENSG00000170906","ENSG00000147684","ENSG00000004779","ENSG00000165264","ENSG00000198886","ENSG00000145494","ENSG00000125356","ENSG00000123545","ENSG00000090266","ENSG00000128609","ENSG00000198763","ENSG00000119013","ENSG00000174886","ENSG00000140990","ENSG00000213619","ENSG00000189043","ENSG00000178057","ENSG00000160194","ENSG00000164182","ENSG00000136521","ENSG00000167792","ENSG00000115286","ENSG00000139180","ENSG00000023228","ENSG00000185633","ENSG00000183648","ENSG00000130414","ENSG00000110717","ENSG00000212907","ENSG00000147123","ENSG00000198786","ENSG00000198888"],"count":50},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000305"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545339","drugType":"Small molecule","blackBoxWarning":false,"name":"FRUQUINTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fruquintinib","HMPL-013","Hmpl-013"],"count":6,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_1001480","EFO_0000365","MONDO_0008903","EFO_1000657","MONDO_0007254","EFO_0003060","EFO_1001951","EFO_0009878"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL360410","canonicalSmiles":"Oc1ccc(-c2noc3cc(O)ccc23)c(O)c1","inchiKey":"NBTXJDAHLMMIGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360410","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06937"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3653256","canonicalSmiles":"COc1ncc(-c2nc3c(n2C(C)C)[C@H](c2ccc(Cl)cc2)N(c2cc(Cl)cn(C)c2=O)C3=O)c(OC)n1","inchiKey":"AGBSXNCBIWWLHD-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIREMADLIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hdm 201","NVP-HDM 201","Siremadlin"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707245","canonicalSmiles":"O=C(O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1","inchiKey":"YHGSTSNEOJUIRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMIDENEPAG","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omidenepag","UR-7276"],"count":1,"linkedTargets":{"rows":["ENSG00000125384"],"count":1},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707280","drugType":"Antibody","blackBoxWarning":false,"name":"CG250 111IN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG250","Cg250 (111in)","Cg250 111in"],"count":1,"linkedTargets":{"rows":["ENSG00000107159"],"count":1},"linkedDiseases":{"rows":["EFO_0000681"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707362","canonicalSmiles":"CC(C(=O)N1c2ccccc2Sc2ccccc21)N(C)C","inchiKey":"POZJNEBUHLZROM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLAMINOPROPIONYLPHENOTHIAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethylaminopropionylphenothiazine"],"crossReferences":{"drugbank":["DB13672"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707384","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)O.O=C(O)C1CSC(C(=O)O)N1","inchiKey":"LUCWYYXUZVULSK-WCCKRBBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIDIACIC ARGININE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2064047","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tidiacic arginine"],"crossReferences":{"DrugCentral":["4735"],"drugbank":["DB13748"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL374361","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"AHCYMLUZIRLXAA-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-deoxy-UTP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-deoxy-UTP"],"crossReferences":{"drugbank":["DB02333"],"chEBI":["17625"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3951811","canonicalSmiles":"CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl","inchiKey":"BCSHRERPHLTPEE-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3951811","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13060"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989725","canonicalSmiles":"N#Cc1cc(NC(=O)C(=O)O)c(Cl)c(NC(=O)C(=O)O)c1.NC(CO)(CO)CO.NC(CO)(CO)CO","inchiKey":"JJOFNSLZHKIJEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LODOXAMIDE TROMETHAMINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201266","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alomide","Alomide allergy"],"synonyms":["Lodoxamide trometamol","Lodoxamide tromethamine","U-42,585E"],"crossReferences":{"DailyMed":["lodoxamide%20tromethamine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993."}
{"id":"CHEMBL3989977","drugType":"Antibody","blackBoxWarning":false,"name":"EMAPALUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gamifant"],"synonyms":["Emapalumab","Emapalumab-lzsg","NI-0501"],"crossReferences":{"DailyMed":["emapalumab-lzsg"]},"count":2,"approvedIndications":["EFO_0000540","Orphanet_158038"],"linkedTargets":{"rows":["ENSG00000111537"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0000540","Orphanet_158038"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for primary hemophagocytic lymphohistiocytosis and immune system disease."}
{"id":"CHEMBL3989989","drugType":"Gene","blackBoxWarning":false,"name":"AXICABTAGENE CILOLEUCEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axicabtagene ciloleucel","KTE-C19","Yescarta"],"count":4,"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["MONDO_0044889","EFO_0000096","EFO_0000403","EFO_0000574","MONDO_0018906","EFO_1001469","EFO_0005952"],"count":7},"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3990030","drugType":"Unknown","blackBoxWarning":false,"name":"EFIZONERIMOD ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efizonerimod","Efizonerimod alfa","MEDI-6383","MEDI6383","Medi 6383"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL401377","canonicalSmiles":"Brc1cnn2c(NCc3ccncc3)cc(-c3ccccc3)nc12","inchiKey":"JECHSYMSTXETFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401377","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07210"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4090674","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O","inchiKey":"XUNKPNYCNUKOAU-VXJRNSOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4090674","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12648"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297280","canonicalSmiles":"N[C@@H](CNC(=O)CC[C@@H](NC(=O)c1ccc(NCc2c[nH]c3ncnc(=O)c-3n2)cc1)C(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O","inchiKey":"YZSIZVRFVQKMJU-RDGPPVDQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETARFOLATIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EC-20","Etarfolatide"],"crossReferences":{"drugbank":["DB11810"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297334","canonicalSmiles":"O=C(O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)c1ccc([18F])nc1)C(=O)O)C(=O)O","inchiKey":"OLWVRJUNLXQDSP-MVBOSPHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DCFPYL F-18","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4299851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(18f)dcfpyl","Dcfpyl f-18"],"crossReferences":{"drugbank":["DB14805"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297470","canonicalSmiles":"COc1cc(F)ccc1-c1c(C)sc2cnc(Nc3cnn(C4CCNCC4)c3)nc12","inchiKey":"AVIOBQFPAGEICQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAX-40279","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MAX-40279","Max-40279"],"crossReferences":{"drugbank":["DB15191"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297528","canonicalSmiles":"Cc1cn2nc(-c3cc(=O)n4cc(N5CCNC6(CC6)C5)ccc4n3)cc(C)c2n1","inchiKey":"ASKZRYGFUPSJPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RISDIPLAM","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evrysdi"],"synonyms":["RG-7916","RG7916","RO-7034067","RO7034067","Risdiplam"],"crossReferences":{"drugbank":["DB15305"]},"count":1,"approvedIndications":["EFO_0008525"],"linkedTargets":{"rows":["ENSG00000205571"],"count":1},"linkedDiseases":{"rows":["EFO_0008525"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for spinal muscular atrophy."}
{"id":"CHEMBL4297896","drugType":"Unknown","blackBoxWarning":false,"name":"ATU-027","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATU027","Atu-027","Atu027"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297961","drugType":"Unknown","blackBoxWarning":false,"name":"GMA-161","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GMA-161","GMA161","Gma-161","Gma161","HUMANIZED, AGLYCOSYL ANTIBODY, GMA161"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297969","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-3359609","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Feladilimab","GSK-3359609","GSK3359609","Gsk 3359609","Gsk-3359609","Gsk3359609"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297971","drugType":"Protein","blackBoxWarning":false,"name":"PEPTIDE YY HUMAN (3-36)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gt-001","Peptide yy (3-36)","Peptide yy human (3-36)","Pyy3-36"],"count":2,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL43","canonicalSmiles":"COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12","inchiKey":"XCPGHVQEEXUHNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMSACRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amsidyl"],"synonyms":["Amsacrine","CI-880","M-AMSA","NCI-249992","NSC-156303","NSC-249992","SN-11841","SN-21429"],"crossReferences":{"PubChem":["11110803","137181","50110958"],"Wikipedia":["Amsacrine"],"drugbank":["DB00276"],"chEBI":["2687"]},"childChemblIds":["CHEMBL1256655","CHEMBL3229103","CHEMBL540070"],"count":4,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000131747","ENSG00000077097"],"count":2},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0000198","EFO_0000222"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 3 investigational indications."}
{"id":"CHEMBL438945","canonicalSmiles":"CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC","inchiKey":"XKWCTHKJQNUFOQ-HRPSIEBRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"HUMAN NEUROPEPTIDE Y","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human neuropeptide y"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL444965","canonicalSmiles":"CC(=O)OO","inchiKey":"KFSLWBXXFJQRDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHANEPEROXOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Peracetic Acid"],"crossReferences":{"PubChem":["144205955"],"Wikipedia":["Peracetic_acid"],"drugbank":["DB14556"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL44857","canonicalSmiles":"CCCOC(C)=O","inchiKey":"YKYONYBAUNKHLG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETIC ACID PROPYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetic Acid Propyl Ester"],"crossReferences":{"PubChem":["144209210"],"Wikipedia":["Propyl_acetate"],"drugbank":["DB01670"],"chEBI":["40116"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL452800","canonicalSmiles":"CCCN1CCC(c2nc3cccc(C(N)=O)c3[nH]2)CC1","inchiKey":"KXSIHXHEHABEJX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"A-620223","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-620223"],"crossReferences":{"drugbank":["DB07330"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4572304","canonicalSmiles":"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1.O.O.O","inchiKey":"FXWCAVDTCCCJHE-JEZXJMRTSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4572304","maximumClinicalTrialPhase":0,"parentId":"CHEMBL34259","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45844","canonicalSmiles":"O=CN(C1CCCC1)C1CCC1","inchiKey":"DWGVYBRKKSJLNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOBUTYL(CYCLOPENTYL)FORMAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04065"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459324","canonicalSmiles":"CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@]314","inchiKey":"GVGLGOZIDCSQPN-PVHGPHFFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIACETYLMORPHINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diacetylmorphine","IDS-NH-001","IDS-NH-001(SECT.3)","J6.494G"],"crossReferences":{"PubChem":["144206165"],"Wikipedia":["Heroin"],"drugbank":["DB01452"],"chEBI":["27808"]},"childChemblIds":["CHEMBL2106627"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594316","drugType":"Antibody","blackBoxWarning":false,"name":"CROVALIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crovalimab","RG-6107","RG6107","RO-7112689","RO7112689","Ro7112689","SKY-59","SKY59"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594420","canonicalSmiles":"Cc1c[nH]c(-c2ccc(-c3ccc(NC(=O)Nc4c(F)cc(F)cc4F)cc3F)c3c2C(=O)NC3)n1","inchiKey":"MWHHJYUHCZWSLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CG-806","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG'806","CG-806","CG806","Cg-806"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594586","drugType":"Unknown","blackBoxWarning":false,"name":"PGT-121","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PGT-121","PGT121","Pgt-121","Pgt121"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460102","canonicalSmiles":"Cc1ncc(-c2nc(Nc3ccc(C(=O)N4CC[C@H](N(C)C)C4)cc3)ncc2F)n1C(C)C","inchiKey":"BACSZMCLZIDTIO-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL460102","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07936"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL47050","canonicalSmiles":"OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"MDLAAYDRRZXJIF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENFLURIDOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Semap"],"synonyms":["MCN-JR-16,341","Micefal","Penfluridol","R 16,341","Semap"],"crossReferences":{"PubChem":["144207095","170466197","29217623"],"Wikipedia":["Penfluridol"],"drugbank":["DB13791"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL478409","canonicalSmiles":"COCCNS(=O)(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1","inchiKey":"LDXLQEXLXZCYSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478409","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07790"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485940","canonicalSmiles":"COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(C)n1","inchiKey":"QKLSCPPJEVXONT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAMETOMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfametomidine"],"crossReferences":{"PubChem":["144206847"],"Wikipedia":["Sulfametomidine"],"drugbank":["DB13485"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL496102","canonicalSmiles":"COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1","inchiKey":"HEAIZQNMNCHNFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-208","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-208","Amg 208","Amg-208"],"crossReferences":{"PubChem":["174006590"],"drugbank":["DB08079"],"chEBI":["90626"]},"count":2,"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL496574","canonicalSmiles":"CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1","inchiKey":"KQGTYXRWSIBDOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL496574","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07254"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL503160","canonicalSmiles":"O=C(O)/C=C/C(=O)O","inchiKey":"VZCYOOQTPOCHFL-OWOJBTEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUMARIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-297","E297","FEMA NO. 2488","Fumaric Acid","Fumaric acid","INS NO.297","INS-297","Monosodium fumarate","NSC-2752"],"crossReferences":{"PubChem":["144208967","144213143","17389670","69355","85148759"],"Wikipedia":["Fumaric_acid"],"drugbank":["DB01677"],"chEBI":["18012"]},"count":2,"approvedIndications":["EFO_0000676"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psoriasis and has 1 investigational indication."}
{"id":"CHEMBL504760","canonicalSmiles":"CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2","inchiKey":"DSSYKIVIOFKYAU-XCBNKYQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMPHOR","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Camphor","Camphor d-form","Camphora","Cinnamomum camphora","D-camphor","Dl-camphor","FEMA NO. 2230","FEMA NO. 4513","Trans-pi-oxocamphor"],"crossReferences":{"PubChem":["144204546","144209385","144213369","170465497","17389023","17389071","26752736","29215100","49816688","50105387"],"drugbank":["DB01744"],"chEBI":["15396"]},"count":2,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL51","canonicalSmiles":"O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1","inchiKey":"FPCCSQOGAWCVBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KETANSERIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sufrexal"],"synonyms":["Ketanserin","R-41,468","R-41468"],"crossReferences":{"PubChem":["104171396","11113781","144204416","170466645","26747132","26747133","26751962","26755333","50103875","50104634","90340810"],"Wikipedia":["Ketanserin"],"drugbank":["DB12465"],"chEBI":["6123"]},"childChemblIds":["CHEMBL2062337","CHEMBL1724541","CHEMBL1628637","CHEMBL1256709","CHEMBL4303471"],"count":3,"approvedIndications":["EFO_0000537"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hypertension and has 2 investigational indications."}
{"id":"CHEMBL515606","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O","inchiKey":"HHHKFGXWKKUNCY-FHWLQOOXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CILAZAPRIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inhibace","Vascace"],"synonyms":["Cilazapril","RO 31-2848/006"],"crossReferences":{"PubChem":["144206524"],"Wikipedia":["Cilazapril"],"drugbank":["DB01340"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL522387","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1","inchiKey":"HJWMLCDGRWWLAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL522387","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06882"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL523395","canonicalSmiles":"O=C(Nc1ccccc1C(=O)O)c1cccc(S(=O)(=O)N2CCc3ccccc3C2)c1","inchiKey":"GYILVHHTCYNIOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW9371","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW9371"],"crossReferences":{"drugbank":["DB07691"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL525239","canonicalSmiles":"C/C(=C\\CNc1ncnc2[nH]cnc12)CO","inchiKey":"UZKQTCBAMSWPJD-FARCUNLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Trans-Zeatin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trans-Zeatin"],"crossReferences":{"PubChem":["11113291","26754340","47193867"],"drugbank":["DB11337"],"chEBI":["16522"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559638","canonicalSmiles":"O=C1c2cccc3c(NCCO)ccc(c23)C(=O)N1c1cccc(Br)c1","inchiKey":"JZCUVYNOSDWORZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL559638","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08701"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566315","canonicalSmiles":"CC[C@@H]1[C@@H]2C[C@H](O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@H]3[C@H](C)CCC(=O)O)[C@@H]2[C@@H]1O","inchiKey":"ZXERDUOLZKYMJM-ZWECCWDJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OBETICHOLIC ACID","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ocaliva"],"synonyms":["DSP-1747","INT-747","Obeticholic acid"],"crossReferences":{"DailyMed":["obeticholic%20acid"],"drugbank":["DB05990"]},"count":10,"approvedIndications":["EFO_0004267","EFO_1001486"],"linkedTargets":{"rows":["ENSG00000012504"],"count":1},"linkedDiseases":{"rows":["MONDO_0001751","EFO_0003095","HP_0002024","EFO_0004267","HP_0002014","EFO_0001421","EFO_1001249","EFO_1001345","EFO_1001486","EFO_0001073","Orphanet_98306"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for biliary liver cirrhosis and primary biliary cirrhosis and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL588046","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.Cl","inchiKey":"LBSFSRMTJJPTCW-DSXUQNDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUININE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Quinine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL64579","canonicalSmiles":"N=C(N)c1ccc2[nH]c(-c3cccc(OC4CCCC4)c3O)cc2c1","inchiKey":"CFSQPEBVGUSQII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL64579","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03173"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL65567","canonicalSmiles":"CN1CC(=O)N=C1N","inchiKey":"DDRJAANPRJIHGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CREATININE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Creatinine","NSC-13123"],"crossReferences":{"PubChem":["144205069","170466777","26749779","50085985"],"Wikipedia":["Creatinine"],"drugbank":["DB11846"],"chEBI":["16737"]},"childChemblIds":["CHEMBL1518203"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL70046","canonicalSmiles":"O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)cc1/C=C/Br","inchiKey":"GCQYYIHYQMVWLT-HQNLTJAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORIVUDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Japan"],"year":1993},"tradeNames":["Bravavir"],"synonyms":["Brovavir","Bv-arau","SO 32,756","SO-32756","SQ 32,756","SQ-32756","Sorivudine","YN-72"],"crossReferences":{"drugbank":["DB11998"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication. It was withdrawn in Japan  in 1993."}
{"id":"CHEMBL711","canonicalSmiles":"O=C1c2ccccc2C(=O)C1c1ccccc1","inchiKey":"NFBAXHOPROOJAW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENINDIONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dindevan","Hedulin"],"synonyms":["NSC-41693","Phenindione","Phenylindanedione"],"crossReferences":{"PubChem":["11112218","11532881","144203926","170465130","26748198","26748199","50107356","50107357","56423141"],"Wikipedia":["Phenindione"],"drugbank":["DB00498"],"chEBI":["8066"]},"count":2,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["HP_0004419","EFO_0002950"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for recurrent thrombophlebitis and has 1 investigational indication."}
{"id":"CHEMBL7390","canonicalSmiles":"COc1ccc(S(=O)(=O)N2CN(Cc3ccccc3)C(=O)C[C@@H]2C(=O)NO)cc1","inchiKey":"SUSMVCKSLVPRCL-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL7390","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04140"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL79993","canonicalSmiles":"O=C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1","inchiKey":"ORZXYSPOAVJYRU-HOTGVXAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Z-PRO-PROLINAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JTP-4819"],"crossReferences":{"PubChem":["26756775"],"drugbank":["DB03535"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL85","canonicalSmiles":"Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2","inchiKey":"RAPZEAPATHNIPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RISPERIDONE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Perseris kit","Risperdal","Risperdal Consta Long Acting","Risperdal M","Risperdal M-Tab","Risperdal consta","Risperdal quicklet","Risperidone"],"synonyms":["LY-03004","LY03004","N05AX08","Perseris","R 64 766","R-64,766","R-64-766","R-64766","RCN-3028","RCN3028","Risperidone"],"crossReferences":{"DailyMed":["risperidone"],"PubChem":["104171228","11111724","11111725","124881313","124881314","144203804","170464925","26719830","26753640","49666400","50106974","50106975","50123965","85231208"],"Wikipedia":["Risperidone"],"drugbank":["DB00734"],"chEBI":["8871"]},"count":25,"approvedIndications":["EFO_0000289","EFO_0003015","EFO_0003758","EFO_0005407","EFO_0000692","EFO_0005411"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0004938","EFO_0002610","EFO_0004718","EFO_0004280","EFO_0004216","MONDO_0002009","HP_0000726","EFO_0000249","EFO_0003015","EFO_0003847","EFO_0003757","EFO_0009267","Orphanet_778","EFO_0010642","MONDO_0002046","EFO_0000289","MONDO_0002050","EFO_0009854","EFO_0003761","EFO_0004701","EFO_0005230","EFO_0000692","EFO_0004215","EFO_0003888","EFO_0003756","HP_0010865","HP_0012076","MONDO_0001087","EFO_0000677","EFO_0003758","EFO_1000904","EFO_0009963","EFO_0005407","EFO_0001358","EFO_0003852","HP_0000713","Orphanet_399","EFO_0003890","MONDO_0002491","Orphanet_79292","EFO_0004895","EFO_0005611","EFO_0005411"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 6 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL915","canonicalSmiles":"CCCc1c2oc(C(=O)[O-])cc(=O)c2cc2c(=O)cc(C(=O)[O-])n(CC)c12.[Na+].[Na+]","inchiKey":"JQEKDNLKIVGXAU-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"NEDOCROMIL SODIUM","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL746","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alocril","Nedocromil sodium","Rapitil","Tilade","Tilarin"],"synonyms":["FPL 59002KP","FPL-59002KP","Nedocromil sodium"],"crossReferences":{"DailyMed":["nedocromil%20sodium"],"chEBI":["7493"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992."}
